Alaska Permanent Fund’s Elevance Health ELV Stock Holding History

Alaska Permanent Fund’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,164	Closed	-$910K	–	144
2025 Q1	$910K	Hold	2,164	–	–	0.01%	354
2024 Q4	$798K	Hold	2,164	–	–	0.01%	368
2024 Q3	$1.13M	Hold	2,164	–	–	0.02%	353
2024 Q2	$1.15M	Buy	2,164 +1,481	+217%	+$783K	0.02%	351
2024 Q1	$354K	Buy	683 +618	+951%	+$307K	0.01%	427
2023 Q4	$30.7K	Buy	+65	New	+$30.1K	﹤0.01%	444
2021 Q2	–	Sell	-8,600	Closed	-$3.09M	–	231
2021 Q1	$3.09M	Hold	8,600	–	–	0.06%	139
2020 Q4	$2.76M	Hold	8,600	–	–	0.05%	129
2020 Q3	$2.31M	Buy	+8,600	New	+$2.31M	0.04%	53

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Alaska Permanent Fund's ELV Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,164 shares — an estimated $910K sold.

Alaska Permanent Fund first reported a position in ELV in Q3 2020 and held it in 9 quarters. The position peaked at $3.09M in Q1 2021. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Alaska Permanent Fund reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 2,164 Elevance Health shares in Q2 2025, an estimated $910K.
Alaska Permanent Fund first reported a position in Elevance Health in Q3 2020 and held it in 9 quarters.
Alaska Permanent Fund's Elevance Health position peaked at $3.09M in Q1 2021.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.